Arkolith/Insider Trading/TSHA/Form 4

Session R.A. II

10% OwnerTaysha Gene Therapies, Inc. (TSHA) · full profile →Form 4 · filed Jul 14, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$61K
Net Open-Market Flow
-$61K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 13, 2023Sell(S)5K$0.70$4K8.9M
Jul 12, 2023Sell(S)81K$0.71$57K8.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-032986) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML